Hashkes PJ, Laxer RM, Simon A. Textbook of Autoinflammation. Basel: Springer International Publishing AG; 2019.

Book  Google Scholar 

Bayes-Genis A, Adler Y, de Luna AB, Imazio M. Colchicine in Pericarditis. Eur Heart J. 2017;38(22):1706–9.

Article  CAS  PubMed  Google Scholar 

Nerlekar N, Beale A, Harper RW. Colchicine—a short history of an ancient drug. Med J Aust. 2014;201(11):687–8.

Article  PubMed  Google Scholar 

Graham W, Roberts JB. Intravenous colchicine in the management of gouty arthritis. Ann Rheum Dis. 1953;12(1):16–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eigsti OJ, Dustin P Jr.. Colchicine in Agriculture, Medicine, Biology and Chemistry. Ames: Iowa State College Press; 1955.

Book  Google Scholar 

Hartung EF. History of the use of colchicum and related medicaments in gout; with suggestions for further research. Ann Rheum Dis. 1954;13(3):190–200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malkinson FD. Colchicine. New uses of an old, old drug. Arch Dermatol. 1982;118(7):453–7.

Article  CAS  PubMed  Google Scholar 

Deftereos S, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K, et al. Colchicine and the heart: pushing the envelope. J Am Coll Cardiol. 2013;62(20):1817–25.

Article  CAS  PubMed  Google Scholar 

Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J. 2021;42(28):2745–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roubille F, Bouabdallaoui N, Kouz S, Waters DD, Diaz R, Maggioni AP, et al. Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47(3):467–70.

Article  CAS  PubMed  Google Scholar 

Ferron GM, Rochdi M, Jusko WJ, Scherrmann JM. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses. J Clin Pharmacol. 1996;36(10):874–83.

Article  CAS  PubMed  Google Scholar 

Chappey ON, Niel E, Wautier JL, Hung PP, Dervichian M, Cattan D, et al. Colchicine disposition in human leukocytes after single and multiple oral administration. Clin Pharmacol Ther. 1993;54(4):360–7.

Article  CAS  PubMed  Google Scholar 

Marchetti S, Mazzanti R, Beijnen JH, Schellens JH. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P‑glycoprotein). Oncologist. 2007;12(8):927–41.

Article  PubMed  Google Scholar 

Rochdi M, Sabouraud A, Girre C, Venet R, Scherrmann JM. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur J Clin Pharmacol. 1994;46(4):351–4.

Article  CAS  PubMed  Google Scholar 

Ben-Chetrit E, Scherrmann JM, Zylber-Katz E, Levy M. Colchicine disposition in patients with familial Mediterranean fever with renal impairment. J Rheumatol. 1994;21(4):710–3.

CAS  PubMed  Google Scholar 

SmPC. Colctab. 2022. https://aspregister.basg.gv.at/document/servlet?action=show&zulnr=141381&type=DOTC_FACH_INFO. Zugegriffen: 11. Nov. 2024.

Tufan A, Babaoglu MO, Akdogan A, Yasar U, Calguneri M, Kalyoncu U, et al. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. J Rheumatol. 2007;34(7):1540–4.

CAS  PubMed  Google Scholar 

The Rheumatologist. FDA Enforcement Against Injectable Colchicine. 2008. https://www.the-rheumatologist.org/article/fda-enforcement-against-injectable-colchicine. Zugegriffen: 11. Nov. 2024.

Vrachatis DA, Papathanasiou KA, Giotaki SG, Iliodromitis KE, Papaioannou TG, Stefanini GG, et al. Repurposing colchicine’s journey in view of drug-to-drug interactions. A review. Toxicol Rep. 2021;8:1389–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stamp LK, Horsley C, Te Karu L, Dalbeth N, Barclay M. Colchicine: the good, the bad, the ugly and how to minimize the risks. Rheumatology. 2024;63(4):936–44.

Article  CAS  PubMed  Google Scholar 

Terkeltaub RA, Furst DE, Digiacinto JL, Kook KA, Davis MW. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Arthritis Rheum. 2011;63(8):2226–37.

Article  CAS  PubMed  Google Scholar 

Sautner J. Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations. Z Rheumatol. 2014;73(9):836–42.

Article  CAS  PubMed  Google Scholar 

Huang R, Duan J, Huang W, Cheng Y, Zhu B, Li F. Inhibition of CYP1A1 Alleviates Colchicine-Induced Hepatotoxicity. Toxins. 2024;16(1):35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology. 2009;48(2):ii9–ii14.

CAS  PubMed  Google Scholar 

Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis. 2018;77(7):1048–52.

Article  CAS  PubMed  Google Scholar 

Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649–62.

Article  PubMed  Google Scholar 

Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):S11–S6.

Article  PubMed  Google Scholar 

Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843–55.

Article  CAS  PubMed  Google Scholar 

Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LTH, Dehlin M. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res Ther. 2018;20(1):108.

Article  PubMed  PubMed Central  Google Scholar 

Fisher MC, Rai SK, Lu N, Zhang Y, Choi HK. The unclosing premature mortality gap in gout: a general population-based study. Ann Rheum Dis. 2017;76(7):1289–94.

Article  PubMed  Google Scholar 

Kuo CF, Luo SF. Gout: Risk of premature death in gout unchanged for years. Nat Rev Rheumatol. 2017;13(4):200–1.

Article  PubMed  Google Scholar 

Ferguson LD, Molenberghs G, Verbeke G, Rahimi K, Rao S, McInnes IB, et al. Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol. 2024;6(3):e156–e67.

Article  CAS  PubMed  Google Scholar 

Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, et al. Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh). Z Rheumatol. 2016;75(2):11–60.

Article  PubMed  Google Scholar 

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42.

Article  CAS  PubMed